DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ovarian
Cancer – Market Insights, Epidemiology and Market Forecast-2020-US”
report to their offering.
The report provides an overview of the disease and global market size of
the Ovarian Cancer for the United States. It also includes global
historical and forecasted epidemiological data for the diagnosed
incident cases of Ovarian Cancer from 2012-2020.
The forecasted patient population of ovarian cancer will decrease at a
CAGR of 0.54% from 2012 to 2020 and the worldwide Ovarian cancer market
is estimated to be 921.2 million by 2020. The report is built using data
and information sourced from proprietary databases, primary and
secondary research and in-house forecast model analysis by Publisher
team of industry experts.
Scope of the Report:
Report covers the disease overview, current treatment options,
prescription drugs and emerging therapies.
The Report also covers the detailed global historical and forecasted
epidemiological data covering United States from 2012-2020.
It also provides Market size of Ovarian Cancer for United States and
forecasted Market size to 2020.
- AbbVie Inc.
- Oasmia Pharmaceutical AB
- Novartis Pharmaceuticals
- Baxter Oncology
- Medison Pharma
- Merck KGaA
Key Topics Covered:
1 Report Introduction
2 Executive Summary
3 Ovarian Cancer Market Overview at a Glance
4 Treatment Landscape
5 Epidemiology and Patient Population
6 Current Medical Practice and Therapies in Use
7 Emerging Therapies
8 United States Market Assessment
9 Consulting Services
For more information visit http://www.researchandmarkets.com/research/g9jqtd/ovarian_cancer
Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716